ES2149347T3 - Composiciones farmaceuticas de verotoxinas y tratamientos medicos con las mismas. - Google Patents

Composiciones farmaceuticas de verotoxinas y tratamientos medicos con las mismas.

Info

Publication number
ES2149347T3
ES2149347T3 ES95908853T ES95908853T ES2149347T3 ES 2149347 T3 ES2149347 T3 ES 2149347T3 ES 95908853 T ES95908853 T ES 95908853T ES 95908853 T ES95908853 T ES 95908853T ES 2149347 T3 ES2149347 T3 ES 2149347T3
Authority
ES
Spain
Prior art keywords
verotoxins
pharmaceutical compositions
same
medical treatments
verotoxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95908853T
Other languages
English (en)
Inventor
Clifford A Lingwood
Richard Hill
Hannah Farkas-Himsley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GEVA RUTH EXECUTOR FOR DEC
KROYANKER LEORAH EXECUTOR FOR
Original Assignee
GEVA RUTH EXECUTOR FOR DEC
KROYANKER LEORAH EXECUTOR FOR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GEVA RUTH EXECUTOR FOR DEC, KROYANKER LEORAH EXECUTOR FOR filed Critical GEVA RUTH EXECUTOR FOR DEC
Application granted granted Critical
Publication of ES2149347T3 publication Critical patent/ES2149347T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE HA DESCRITO QUE LAS COMPOSICIONES FARMACEUTICAS CON VEROTOXINAS CONOCIDAS, EN PARTICULAR LA VEROTOXINA 1, RESULTAN UTILES PARA EL TRATAMIENTO DE LAS NEOPLASIAS DE MAMIFEROS, EN ESPECIAL EL CANCER DE OVARIOS Y EL CANCER DE PIEL. SORPRENDENTEMENTE, A PESAR DE QUE LA ACTIVIDAD ANTINEOPLASICA DE LA VEROTOXINA 1 SE HABIA DEMOSTRADO PREVIAMENTE IN VITRO, SE HA DEMOSTRADO QUE DOSIS NO LETALES DE VEROTOXINA 1 SON TERAPEUTICAMENTE ANTINEOPLASICAS IN VIVO.
ES95908853T 1994-02-22 1995-02-20 Composiciones farmaceuticas de verotoxinas y tratamientos medicos con las mismas. Expired - Lifetime ES2149347T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002116179A CA2116179C (en) 1994-02-22 1994-02-22 Verotoxin pharmaceutical compositions and medical treatments therewith

Publications (1)

Publication Number Publication Date
ES2149347T3 true ES2149347T3 (es) 2000-11-01

Family

ID=4152948

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95908853T Expired - Lifetime ES2149347T3 (es) 1994-02-22 1995-02-20 Composiciones farmaceuticas de verotoxinas y tratamientos medicos con las mismas.

Country Status (10)

Country Link
US (1) US6228370B1 (es)
EP (1) EP0746337B1 (es)
JP (1) JPH10500103A (es)
AT (1) ATE193451T1 (es)
AU (1) AU701100B2 (es)
CA (1) CA2116179C (es)
DE (1) DE69517302T2 (es)
ES (1) ES2149347T3 (es)
NZ (1) NZ331165A (es)
WO (1) WO1995022349A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835710B1 (en) 1994-02-22 2004-12-28 Hsc Research & Development Limited Partnership Verotoxin pharmaceutical compositions and medical treatments therewith
WO1998051326A1 (en) * 1997-05-16 1998-11-19 Hsc Research And Development Limited Partnership Inhibition of angiogenesis by verotoxins
RU2217166C2 (ru) 1998-05-20 2003-11-27 Тейдзин Лимитед Гуманизированные антитела, которые распознают веротоксин ii, и продуцирующая их линия клеток
WO2000061183A2 (en) * 1999-04-09 2000-10-19 Hsc Research And Development Limited Partnership Verotoxin treatment of lymphomas
WO2000066714A2 (en) * 1999-05-03 2000-11-09 The Governors Of The University Of Alberta Shiga-like toxin as an enriching and purging agent
EP1496116B1 (en) 2002-02-04 2010-06-16 Yoshida, Hideo Anticancer agents using vero toxin variants

Also Published As

Publication number Publication date
AU701100B2 (en) 1999-01-21
ATE193451T1 (de) 2000-06-15
CA2116179C (en) 2008-01-08
WO1995022349A1 (en) 1995-08-24
EP0746337B1 (en) 2000-05-31
AU1703195A (en) 1995-09-04
CA2116179A1 (en) 1995-08-23
EP0746337A1 (en) 1996-12-11
US6228370B1 (en) 2001-05-08
DE69517302D1 (de) 2000-07-06
JPH10500103A (ja) 1998-01-06
NZ331165A (en) 2000-01-28
DE69517302T2 (de) 2001-01-18

Similar Documents

Publication Publication Date Title
ATE80790T1 (de) Zusammensetzung zur behandlung der haut.
ES2080837T5 (es) Uso de acido hialuronico en combinacion con acido ascorbico, agentes antitumorales y/o faine para el tratamiento del cancer.
PT933995E (pt) Metodo para tratamento de lesao endotelial
DE60124715D1 (de) Er produktion von beta-endorphin
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
CY1105818T1 (el) Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου
DK0462194T3 (da) Fibroblastvækstfaktor-(FGF)-baserede stabiliserede sammensætninger
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
ATE162804T1 (de) Selbstvernetztes gellangummi
ATE340561T1 (de) Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen
ES2149347T3 (es) Composiciones farmaceuticas de verotoxinas y tratamientos medicos con las mismas.
CA2351947A1 (en) Hyperforin as cytostatic agent and hyperforin ointment or cream as application form
MX9203405A (es) Compuestos activos para usarse en el tratamiento de tumores.
GB9509888D0 (en) Terpenoidic derivatives useful as antitumour agents
CA2163716A1 (en) Verotoxin pharmaceutical compositions and medical treatments therewith
ATE141510T1 (de) Arzneimittel enthaltend cd14
ATE83657T1 (de) Pharmazeutische zusammensetzung.
RU94024337A (ru) Антиметастатическое средство
FR2644459B1 (fr) Esters retinoiques de l-cladinose, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
IT9048186A0 (it) Impiego teperautico della ranitidina nella cura di ferite interessantila cute e i tessuti sottostanti
PT1150981E (pt) Composto nucleosidico terapeutico
ES2063057T3 (es) Esteres aromaticos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
IT1265649B1 (it) Prodotto dermatologico per uso topico, relativo processo di produzione ed ulizzazione terapeutica nelle ustioni e patologie cutanee.
RU94001389A (ru) Способ лечения псориаза
RU94021815A (ru) Способ лечения злокачественных новообразований

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 746337

Country of ref document: ES